Definitions of response and remission for the Robarts Histopathology Index
Open accessThe DOI matches its Crossref record.
Abstract
The Robarts Histopathology Index (RHI) is a recently validated instrument that measures histological disease activity in ulcerative colitis.1 Given the increasing importance and use of histology in UC as a treatment outcome, additional evaluation and clarification of the definitions for histological remission and response using the RHI is needed. During the development of the RHI, we demonstrated that most patients in clinical or endoscopic remission had an RHI≤6. However, an RHI≤6 should not be used to define histological remission as was recently suggested by Magro et al .2 Rather, the minimal criteria for histological remission should be the absence of neutrophils from the mucosa (both lamina propria and epithelium), as neutrophils have long been used to define histologically active disease.3 Furthermore, the presence of mucosal neutrophils in biopsies from patients in clinical remission predicts clinical relapse.4 Using the RHI, an absence of mucosal neutrophils is defined as RHI≤3 with the additional requirement of subscores of 0 for lamina propria neutrophils and 0 for neutrophils in epithelium. Given that basal plasmacytosis has also been suggested as an important histological predictor of adverse outcomes,5 an alternate histological endpoint that requires both the absence of mucosal neutrophils and basal plasmacytosis defined as an RHI≤1 could be attractive. However, this composite definition might be too …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Targeting sphingosine-1-phosphate signaling in immune-mediated diseases: beyond multiple sclerosis
Pérez-Jeldres, T., Alvarez-Lobos, M., & Rivera-Nieves, J. (2021) · Drugs · doi:10.1007/s40265-021-01528-8 · Cited by 197
Gui, X., Bazarova, A., del Amor, R., Vieth, M., de Hertogh, G., Villanacci, V., Zardo, D., Parigi, T. L., Røyset, E. S., Shivaji, U. N., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326376 · Cited by 136
Iacucci, M., Parigi, T. L., Del Amor, R., Meseguer, P., Mandelli, G., Bozzola, A., Bazarova, A., Bhandari, P., Bisschops, R., Danese, S., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.031 · Cited by 127
Iacucci, M., Jeffery, L., Acharjee, A., Grisan, E., Buda, A., Nardone, O. M., Smith, S. C. L., Labarile, N., Zardo, D., Ungar, B., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac233 · Cited by 50
Metadata
- Authors
- Pai, R. K., Khanna, R., D’Haens, G. R., Sandborn, W. J., Jeyarajah, J., Feagan, B. G., Vande Casteele, N., & Jairath, V.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2018-10-26
- Volume
- 68
- Issue
- 11
- Pages
- 2101-2102
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2898372257
- Cited by
- 43
- References
- 0
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Definitions of response and remission for the Robarts Histopathology Index. https://app.cochat.ai/papers/10.1136/gutjnl-2018-317547
- The paper
- Pai, R. K., Khanna, R., D’Haens, G. R., Sandborn, W. J., Jeyarajah, J., Feagan, B. G., Vande Casteele, N., & Jairath, V. (2019). Definitions of response and remission for the Robarts Histopathology Index. Gut. https://doi.org/10.1136/gutjnl-2018-317547
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.